Skip to main content
logo
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
104.14
-0.60 (-0.57%)
Sep 2, 2026, 11:32 AM EDT - Market open

Rhythm Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7,1707,1433,4402,7171,641502
Market Cap Growth
4.66%107.64%26.64%65.56%227.08%-61.83%
Enterprise Value
6,9496,9873,3972,4191,295176
Last Close Price
104.74107.0455.9845.9729.129.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
30.0037.6526.4435.0969.42159.06
PB Ratio
69.9926.4620.9116.006.211.77
P/TBV Ratio
73.3653.41221.1716.696.401.80

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
29.0736.8226.1031.2454.7955.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.510.420.690.630.290.01
Net Debt / Equity Ratio
-1.02-1.02-1.26-0.99-0.97-1.03
Net Debt / EBITDA Ratio
1.111.451.210.921.441.73
Net Debt / FCF Ratio
2.082.371.821.241.472.00
Asset Turnover
0.590.440.360.220.070.01
Inventory Turnover
1.070.880.981.611.41-
Quick Ratio
3.003.922.945.278.536.81
Current Ratio
3.454.413.245.588.907.10
Return on Equity (ROE)
-117.05%-90.45%-155.91%-85.10%-66.05%-30.89%
Return on Assets (ROA)
-30.96%-27.51%-29.84%-32.22%-31.45%-41.15%
Return on Capital Employed (ROCE)
-64.00%-51.30%-62.50%-66.40%-52.30%-59.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.92%-2.75%-7.58%-6.80%-11.04%-13.88%
FCF Yield
-1.48%-1.63%-3.31%-5.01%-10.59%-29.19%
Buyback Yield / Dilution
-8.09%-6.54%-5.76%-10.65%-5.08%-12.40%
SEC Filings: 10-K · 10-Q